Colinz Laboratories Limited (BOM:531210)
48.51
+2.31 (5.00%)
At close: May 26, 2026
Colinz Laboratories Market Cap
Colinz Laboratories has a market cap or net worth of 128.3 million as of May 27, 2026. Its market cap has increased by 0.59% in one year.
Market Cap
128.30M
Enterprise Value
46.91M
Revenue
61.36M
Ranking
n/a
PE Ratio
24.97
Stock Price
48.51
Market Cap Chart
Since May 26, 2005, Colinz Laboratories's market cap has increased from 39.08M to 128.30M, an increase of 228.28%. That is a compound annual growth rate of 5.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 122.20M | -9.55% |
| Dec 31, 2025 | 135.10M | -23.12% |
| Dec 31, 2024 | 175.73M | 74.40% |
| Dec 29, 2023 | 100.76M | -48.73% |
| Dec 30, 2022 | 196.55M | 55.52% |
| Dec 31, 2021 | 126.39M | 93.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Desh Rakshak Aushdhalaya | 189.24M |
| Zenith Healthcare | 173.04M |
| Parmax Pharma | 137.34M |
| Emmessar Biotech & Nutrition | 130.90M |
| Norris Medicines | 130.01M |
| Shamrock Industrial Company | 121.74M |
| Ortin Global | 111.81M |
| Beryl Drugs | 96.41M |